CLINICAL_TRIALS
trial_result
· 2012-04-10
Clinical Trial Update: Study of Oglemilast for the Prevention of Asthma. [Phase 2]
Summary
The document reports the completion of a Phase 2 trial evaluating oglemilast for the prevention of exercise-induced asthma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forest Laboratories | Conditions: Exercise-Induced Asthma | Phase 2 | Status: COMPLETED